{"id":155,"date":"2012-06-07T11:14:50","date_gmt":"2012-06-07T15:14:50","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=155"},"modified":"2012-06-07T20:42:48","modified_gmt":"2012-06-08T00:42:48","slug":"vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155","title":{"rendered":"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery?"},"content":{"rendered":"<p>Vistagen Therapeutics, Inc. (VSTA) rose an incredible 10.89% yesterday, closing at a price of $1.12, which was also its intraday high. The stock had been on a declining streak since April and today\u2019s rally could be another sign of volatility. Maybe, though, it\u2019s a start for the company to climb back up.<\/p>\n<p>On May 14th, Vistagen Therapeutics issued an update letter in a PR to its stockholders; a copy of the PR is attached on the current report of Form 8-K.<\/p>\n<p>Vistagen Therapeutics is providing much flair in the field of drug rescue and cell therapy. The company also applies its expertise to therapeutic cell research.<\/p>\n<p>Vistagen\u00b4s methods, along with its enviable experience in stem cell research, play an important part of any drug rescue. For the public use, the company scrutinizes all of its drugs very proficiently before sending them in to the market. Several drugs were abandoned after indications that they could cause adverse effects to the human heart, which has been corroborated by the National Institute of Health, drug development companies, and academic research laboratories.<\/p>\n<p>Vistagen also secures vital US patents for stem cell investigation. Recently, Vistagen has been awarded patent 11\/445,733. This patent incorporates the methods and forms of measuring poisonous outcomes potentially reduced by trial drugs in the stems of liver cells.<\/p>\n<p>Also included in patent 11\/445,733 is the authority to utilize all cells derived from small rodent liver cells, including rats and mice.<\/p>\n<p>Next line permission has also been granted for testing cells in \u00b4vivo\u00b4 organisms or cells from pluripotent-provoked sources. The company can also monitor toxic changes in genes. This patent permits the company to monitor changes in the genes as a way of predicting drug toxins.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vistagen Therapeutics, Inc. (VSTA) rose an incredible 10.89% yesterday, closing at a price of $1.12, which was also its intraday high. The stock had been [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":41703,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[3],"tags":[42],"stock_ticker":[],"class_list":["post-155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-small-cap-stock-news","tag-vsta","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery? - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery? - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Vistagen Therapeutics, Inc. (VSTA) rose an incredible 10.89% yesterday, closing at a price of $1.12, which was also its intraday high. The stock had been [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2012-06-07T15:14:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2012-06-08T00:42:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"770\" \/>\n\t<meta property=\"og:image:height\" content=\"433\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery?\",\"datePublished\":\"2012-06-07T15:14:50+00:00\",\"dateModified\":\"2012-06-08T00:42:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155\"},\"wordCount\":293,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg\",\"keywords\":[\"VSTA\"],\"articleSection\":[\"Small Cap Stock News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155\",\"name\":\"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery? - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg\",\"datePublished\":\"2012-06-07T15:14:50+00:00\",\"dateModified\":\"2012-06-08T00:42:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg\",\"width\":770,\"height\":433},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery? - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155","og_locale":"en_US","og_type":"article","og_title":"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery? - Wall Street PR","og_description":"Vistagen Therapeutics, Inc. (VSTA) rose an incredible 10.89% yesterday, closing at a price of $1.12, which was also its intraday high. The stock had been [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2012-06-07T15:14:50+00:00","article_modified_time":"2012-06-08T00:42:48+00:00","og_image":[{"width":770,"height":433,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery?","datePublished":"2012-06-07T15:14:50+00:00","dateModified":"2012-06-08T00:42:48+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155"},"wordCount":293,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg","keywords":["VSTA"],"articleSection":["Small Cap Stock News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155","url":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155","name":"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery? - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg","datePublished":"2012-06-07T15:14:50+00:00","dateModified":"2012-06-08T00:42:48+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/WallStreet9.jpg","width":770,"height":433},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vistagen-therapeutics-rallies-is-this-the-beginning-of-full-recovery-155#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Vistagen Therapeutics Rallies: Is This The Beginning Of Full Recovery?"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=155"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/155\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/41703"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=155"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}